RNU6-1007P

Across TCGA pan-cancer cohorts, RNU6-1007P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-1007P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-1007P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1007P expression acts as an unfavorable survival marker.

HNSC, LUSC, and ESCA are the cancer types where RNU6-1007P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.163	0.696	.007	72	view →
LUSC	OS	Tertile	All	0.264	0.728	.004	57	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
SKCM	OS	Tertile	All	0.197	0.871	<.001	18	view →
LAML	DFS	Tertile	All	0.140	0.582	.020	18	view →
LUAD	OS	Tertile	All	0.235	0.697	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-1007P–HNSC (DFS)

Open the HNSC breakdown →